Daiichi Sankyo Wants Hold On $3B Ranbaxy Sale Lifted
Japan-based Daiichi Sankyo Co. Ltd. has asked an Indian court to take the hold off its planned $3.2 billion sale of Ranbaxy Laboratories Ltd. to Sun Pharmaceuticals Inc. after Sun Pharma...To view the full article, register now.
Already a subscriber? Click here to view full article